Tradename | Proper name | Company | Number | Date | Products |
---|---|---|---|---|---|
Aldurazyme | laronidase | BioMarin Pharmaceutical | N-125058 RX | 2003-04-30 | 1 products |
Brand Name | Status | Last Update |
---|---|---|
aldurazyme | Biologic Licensing Application | 2024-10-03 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
mucopolysaccharidosis i | — | D008059 | E76.0 |
Expiration | Code | ||
---|---|---|---|
laronidase, Aldurazyme, BioMarin Pharmaceutical Inc. | |||
2110-04-30 | Orphan excl. |
Code | Description |
---|---|
J1931 | Injection, laronidase, 0.1 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Mucopolysaccharidoses | D009083 | — | E76.3 | — | — | — | — | 1 | 1 |
Mucopolysaccharidosis i | D008059 | — | E76.0 | — | — | — | — | 1 | 1 |
Syndrome | D013577 | — | — | — | — | — | — | 1 | 1 |
Lysosomal storage diseases | D016464 | — | — | — | — | — | — | 1 | 1 |
Cognitive dysfunction | D060825 | — | G31.84 | — | — | — | — | 1 | 1 |
Drug common name | Laronidase |
INN | laronidase |
Description | Aldurazyme (laronidase) is an enzyme pharmaceutical. Laronidase was first approved as Aldurazyme on 2003-06-09. It is used to treat mucopolysaccharidosis i in the USA. It has been approved in Europe to treat mucopolysaccharidosis i. |
Classification | Enzyme |
Drug class | enzymes |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL1201595 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB00090 |
UNII ID | WP58SVM6R4 (ChemIDplus, GSRS) |